KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Goodwill & Intangibles (2016 - 2023)

Inovio Pharmaceuticals' Goodwill & Intangibles history spans 12 years, with the latest figure at $10.5 million for Q1 2023.

  • For Q1 2023, Goodwill & Intangibles changed N/A year-over-year to $10.5 million; the TTM value through Mar 2023 reached $10.5 million, changed N/A, while the annual FY2022 figure was $2.1 million, N/A changed from the prior year.
  • Goodwill & Intangibles for Q1 2023 was $10.5 million at Inovio Pharmaceuticals, up from $2.1 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $13.7 million in Q4 2020 and bottomed at $2.1 million in Q4 2022.
  • The 4-year median for Goodwill & Intangibles is $3.3 million (2020), against an average of $6.9 million.
  • The largest annual shift saw Goodwill & Intangibles skyrocketed 304.03% in 2021 before it plummeted 83.04% in 2022.
  • A 4-year view of Goodwill & Intangibles shows it stood at $13.7 million in 2020, then fell by 2.88% to $13.3 million in 2021, then crashed by 83.95% to $2.1 million in 2022, then skyrocketed by 393.62% to $10.5 million in 2023.
  • Per Business Quant, the three most recent readings for INO's Goodwill & Intangibles are $10.5 million (Q1 2023), $2.1 million (Q4 2022), and $2.2 million (Q3 2022).